Log In
BCIQ
Print this Print this
 

Oral APX001

  Manage Alerts
Collapse Summary General Information
Company Eisai Co. Ltd.
DescriptionOral formulation of a small molecule that inhibits fungal enzyme GPI-anchored wall transfer protein 1 (GWT1)
Molecular Target A. fumigatus GPI-anchored wall transfer protein 1 (A. fumigatus GWT1) ; C. albicans GPI-anchored wall transfer protein 1 (C. albicans GWT1)
Mechanism of ActionAntifungal agent
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationFungal infection
Indication DetailsTreat fungal infection
Regulatory Designation U.S. - Orphan Drug (Treat fungal infection)
PartnerAmplyx Pharmaceuticals Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today